Neuronetics Insider Pfanstiel Reports Ownership Change

Pfanstiel Steven 4 Filing Summary
FieldDetail
CompanyPfanstiel Steven
Form Type4
Filed DateMar 24, 2026
Risk Levellow
Pages2
Reading Time3 min
Key Dollar Amounts$1.48, $1.20
Sentimentneutral

Complexity: simple

Sentiment: neutral

Topics: insider-filing, ownership-change, form-4, executive-activity

TL;DR

**Insider Steven Pfanstiel reported a change in Neuronetics ownership, watch for transaction details.**

AI Summary

Steven Pfanstiel, an insider at Neuronetics, Inc., filed a Form 4 on March 24, 2026, indicating a change in his beneficial ownership of the company's securities as of March 19, 2026. This filing, while not detailing specific transactions, signals that an executive's stake in the company has been adjusted. For investors, this matters because changes in insider ownership can sometimes be an early indicator of management's confidence (or lack thereof) in the company's future prospects, potentially influencing stock performance.

Why It Matters

Changes in insider ownership can signal management's view on the company's future, which can influence investor sentiment and stock price.

Risk Assessment

Risk Level: low — This filing is purely informational, reporting a change in beneficial ownership without specifying the nature of the transaction, thus posing minimal direct risk.

Analyst Insight

Investors should monitor for the full Form 4 document to understand the nature of Steven Pfanstiel's transaction (e.g., sale, purchase, grant) to gauge potential implications for Neuronetics, Inc. stock.

Key Players & Entities

  • Steven Pfanstiel (person) — Reporting Person, an insider at Neuronetics, Inc.
  • Neuronetics, Inc. (company) — Issuer of the securities
  • March 24, 2026 (date) — Filing Date of the Form 4
  • March 19, 2026 (date) — Period of Report for the ownership change

Forward-Looking Statements

  • Further details regarding the specific transactions (e.g., buy/sell, grant) will likely be disclosed in subsequent sections of the full Form 4 document, which is not fully provided here. (Steven Pfanstiel) — high confidence, target: N/A

FAQ

Who is the reporting person in this Form 4 filing?

The reporting person is Steven Pfanstiel, identified by CIK 0001856059.

Which company's securities are involved in this filing?

The securities belong to Neuronetics, Inc., identified as the Issuer with CIK 0001227636.

What is the filing date of this Form 4?

The filing date for this Form 4 is March 24, 2026.

What is the period of report for the changes in beneficial ownership?

The period of report for the changes in beneficial ownership is March 19, 2026.

What type of business does Neuronetics, Inc. engage in according to its SIC code?

Neuronetics, Inc. operates in 'Surgical & Medical Instruments & Apparatus' as indicated by SIC 3841.

Filing Stats: 680 words · 3 min read · ~2 pages · Grade level 8.2 · Accepted 2026-03-24 17:52:12

Key Financial Figures

  • $1.48 — ctions at per share prices ranging from $1.48 to $1.20. The Reporting Person undertak
  • $1.20 — per share prices ranging from $1.48 to $1.20. The Reporting Person undertakes to pro

Filing Documents

From the Filing

SEC FORM 4 SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. 1. Name and Address of Reporting Person * Pfanstiel Steven (Last) (First) (Middle) C/O NEURONETICS, INC. 3222 PHOENIXVILLE PIKE (Street) MALVERN PENNSYLVANIA 19355 (City) (State) (Zip) UNITED STATES (Country) 2. Issuer Name and Ticker or Trading Symbol Neuronetics, Inc. [ STIM ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) EVP, CFO and Treasurer 2a. Foreign Trading Symbol 3. Date of Earliest Transaction (Month/Day/Year) 03/19/2026 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person 4. If Amendment, Date of Original Filed (Month/Day/Year) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 03/19/2026 S 16,431 (1) D $ 1.34 (2) 828,781 D Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Explanation of Responses: 1. The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a performance restricted stock unit award. 2. The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.48 to $1.20. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Patrick Devine, as Attorney-in-Fact 03/24/2026 ** Signature of Reporting Person Date Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. * Form 4: SEC 1474 (03-26)

View Full Filing

View this 4 filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.